With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s 4 annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings.

With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation

Comments   Website address where the Plan Summary is posted for the public   File Name * Date * TRA Plan Certifications.pdf 30/04/2018 4:22:30 PM Plan Summary Submission Electronic Submission Company Name Polyone Canada Inc.

TYPICAL PROPERTIES Sample thickness 0.25 in/6.35mm TEMPERATURE FLEXURAL STRENGTH ASTM D790 FLEXURAL MODULUS ASTM D790 °F °C ksi MPa msi GPa -60 -51 173 1193 5.00 34.48 70 21 155 1069 5.11 35.23 160 71 138 952 5.04 34.75 250 121 110 758 4.70 32.41 300 149 78 538 4.22 29.10 -60 -51 176 1211 5.64 38.92 70 21 143 989 5.36 36.98 160 71 120 824 5.57 38.41 250 121 61 423 4.82 33.24 -60 -51 163 1125 4.19 28.88 70 21 120 824 3.85 26.51 160 71 86 595 3.83 26.44 250 121 40 274 3.19 22.00 G la ss /E po xy H ig h Te m p Ep ox y/ G la ss G la ss /V in yl E st er MECHANICAL PERFORMANCE TESTING NOTES Springs were fatigue tested at 4 hz in a cantilevered loading.

在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

STAYING AHEAD OF TRENDS2 1 3 4 5 WHAT ARE THE NEWEST POLYMER TECHNOLOGIES?